IL97638A - Bi-functional compounds and compositions, pharmaceutical preparations containing them and a method for treating them with neuroimmunological diseases in non-human mammals - Google Patents

Bi-functional compounds and compositions, pharmaceutical preparations containing them and a method for treating them with neuroimmunological diseases in non-human mammals

Info

Publication number
IL97638A
IL97638A IL9763891A IL9763891A IL97638A IL 97638 A IL97638 A IL 97638A IL 9763891 A IL9763891 A IL 9763891A IL 9763891 A IL9763891 A IL 9763891A IL 97638 A IL97638 A IL 97638A
Authority
IL
Israel
Prior art keywords
oxo
dihydro
purin
ait
solution
Prior art date
Application number
IL9763891A
Other languages
English (en)
Hebrew (he)
Other versions
IL97638A0 (en
Original Assignee
Glasky Alvin J
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glasky Alvin J filed Critical Glasky Alvin J
Publication of IL97638A0 publication Critical patent/IL97638A0/xx
Publication of IL97638A publication Critical patent/IL97638A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28—Oxygen atom
    • C07D473/30—Oxygen atom attached in position 6, e.g. hypoxanthine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
IL9763891A 1990-03-28 1991-03-21 Bi-functional compounds and compositions, pharmaceutical preparations containing them and a method for treating them with neuroimmunological diseases in non-human mammals IL97638A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/500,789 US5091432A (en) 1990-03-28 1990-03-28 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use

Publications (2)

Publication Number Publication Date
IL97638A0 IL97638A0 (en) 1992-06-21
IL97638A true IL97638A (en) 1999-03-12

Family

ID=23990941

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9763891A IL97638A (en) 1990-03-28 1991-03-21 Bi-functional compounds and compositions, pharmaceutical preparations containing them and a method for treating them with neuroimmunological diseases in non-human mammals

Country Status (17)

Country Link
US (1) US5091432A (fr)
EP (1) EP0522082B1 (fr)
JP (1) JP3198335B2 (fr)
KR (1) KR100194162B1 (fr)
AT (1) ATE154880T1 (fr)
AU (1) AU7678191A (fr)
CA (1) CA2079342C (fr)
CS (1) CS85991A3 (fr)
DE (1) DE69126701T2 (fr)
DK (1) DK0522082T3 (fr)
ES (1) ES2104700T3 (fr)
GR (1) GR3024904T3 (fr)
IE (1) IE81123B1 (fr)
IL (1) IL97638A (fr)
NZ (1) NZ237574A (fr)
TW (1) TW279865B (fr)
WO (1) WO1991014434A1 (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US5447939A (en) * 1994-07-25 1995-09-05 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
PL318293A1 (en) 1994-07-25 1997-06-09 Alvin J Glasky Carbon monoxide dependent guanilyl cyclase modifiers
US5801184A (en) * 1994-07-25 1998-09-01 Glasky; Alvin J. Carbon monoxide dependent guanylyl cyclase modifiers and methods of use
US20020022657A1 (en) * 1998-02-11 2002-02-21 Francine Gervais Methods for modulating neuronal cell death
AU3879899A (en) * 1998-05-04 1999-11-23 Neotherapeutics, Inc. Novel dopamine-like 9-substituted hypoxanthine and methods of use
US6303617B1 (en) * 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6297226B1 (en) * 1999-10-15 2001-10-02 Neotherapeutics, Inc. Synthesis and methods of use of 9-substituted guanine derivatives
US6288069B1 (en) * 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
JP3989247B2 (ja) * 1999-12-06 2007-10-10 ユーロ−セルティーク エス.エイ. ノシセプチン受容体親和性を有するトリアゾスピロ化合物
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
US20020040031A1 (en) * 2000-07-07 2002-04-04 Glasky Michelle S. Methods for prevention of accumulation of amyloid beta peptide in the central nervous system
US6630490B2 (en) 2000-07-07 2003-10-07 Neotherapeutics, Inc. Methods for treatment of disease-induced peripheral neuropathy and related conditions
US20020040032A1 (en) * 2000-07-07 2002-04-04 Glasky Michelle S. Methods for stimulation of synthesis of synaptophysin in the central nervous system
WO2002004449A2 (fr) * 2000-07-07 2002-01-17 Neotherapeutics, Inc. Procedes de traitement d'etats touches par l'activite de transporteuses de plusieurs medicaments
WO2002058736A2 (fr) * 2000-12-12 2002-08-01 Neotherapetics, Inc. Utilisation d'analogues de purine a substitution en position 9 et d'autres molecules pour stimuler la neurogenese
US20020156277A1 (en) * 2001-04-20 2002-10-24 Fick David B. Synthesis and methods of use of purine analogues and derivatives
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US6906190B2 (en) * 2002-01-04 2005-06-14 Ribapharm Inc. Inhibitors for de novo-RNA polymerases and methods of identifying targets for same
AU2004290499C1 (en) 2003-11-03 2011-02-24 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
US7473728B2 (en) * 2004-12-16 2009-01-06 The Goodyear Tire & Rubber Company Dual phase rubber composition and tire with nanocomposite-containing sidewall thereof
EP1836161B1 (fr) 2004-12-22 2016-07-20 BHI Limited Partnership Methodes et compositions de traitement de maladies liees a l'amyloide
ATE481094T1 (de) * 2005-12-22 2010-10-15 Kiacta Sarl Behandlung von diabetischer nephropathie
SI2089417T1 (sl) 2006-10-12 2015-04-30 Bhi Limited Partnership Metode, spojine, sestavki in vektorji za dostavo 3-amino-1-propansulfonske kisline
CA2673022A1 (fr) * 2006-12-22 2008-07-03 Bellus Health (International) Limited Procedes, composes et compositions permettant de traiter des troubles metaboliques et le diabete
EP2922854B1 (fr) * 2012-11-21 2022-05-04 Zoetis Services LLC Synthèse de dérivés d'isoxazoline spirocyclique
CN115521306B (zh) * 2022-09-26 2024-03-26 贵州大学 一种1,2,3,4-四氢-β-咔啉衍生物及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3321369A (en) * 1965-05-26 1967-05-23 Abbott Lab Method of enhancing learning rate and retention level in warm blooded animals
US3438968A (en) * 1966-06-23 1969-04-15 Int Chem & Nuclear Corp Substituted ammonium basic addition salts of ribonucleic acid
US4221910A (en) * 1978-09-15 1980-09-09 Newport Pharmaceuticals International, Inc. 9-(Hydroxy alkyl)purines
US4221909A (en) * 1978-09-15 1980-09-09 Sloan-Kettering Institute For Cancer Research P-Acetamidobenzoic acid salts of 9-(hydroxyalkyl) purines
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
IL64501A (en) * 1980-12-22 1985-07-31 Astra Laekemedel Ab 9-substituted 4-hydroxybutyl guanine derivatives,their preparation and antiviral use
US4728605A (en) * 1984-07-31 1988-03-01 Fudenberg Herman H Methods for recognizing and diagnosing subsets of Alzheimer's disease associated with immune system dysfunction, and for the in vitro testing of possible therapeutic agents for treatment of same
US4952693A (en) * 1984-10-12 1990-08-28 Warner-Lambert Company Oxazolo-pyrimidine derivatives

Also Published As

Publication number Publication date
EP0522082B1 (fr) 1997-07-02
US5091432A (en) 1992-02-25
ES2104700T3 (es) 1997-10-16
DE69126701T2 (de) 1997-12-04
TW279865B (fr) 1996-07-01
JP3198335B2 (ja) 2001-08-13
EP0522082A1 (fr) 1993-01-13
CA2079342A1 (fr) 1991-09-29
DE69126701D1 (de) 1997-08-07
IL97638A0 (en) 1992-06-21
NZ237574A (en) 1993-09-27
WO1991014434A1 (fr) 1991-10-03
GR3024904T3 (en) 1998-01-30
CS85991A3 (en) 1992-02-19
IE910994A1 (en) 1991-10-09
CA2079342C (fr) 2001-10-23
IE81123B1 (en) 2000-03-22
JPH05508390A (ja) 1993-11-25
AU7678191A (en) 1991-10-21
EP0522082A4 (en) 1993-06-09
KR100194162B1 (ko) 1999-06-15
ATE154880T1 (de) 1997-07-15
DK0522082T3 (da) 1997-07-21

Similar Documents

Publication Publication Date Title
US5091432A (en) 9-substituted hypoxanthine bi-functional compounds and their neuroimmunological methods of use
CN104837825B (zh) 鲁顿酪氨酸激酶抑制剂
JP6458039B2 (ja) Btk及び/又はjak3キナーゼの活性を抑制する化合物
EP2010505B1 (fr) Composés hétérocycliques et leurs utilisations dans le traitement de troubles sexuels
TWI711610B (zh) 布魯頓氏酪胺酸激酶抑制劑
JP6291132B2 (ja) ブルートンチロシンキナーゼ阻害剤
EP3765462B1 (fr) Composés de (2-azabicyclo [3.1.0] hexan-2-yl) pyrazolo [1, 5-a] pyrimidine et imidazo [1, 2-b] pyridazine substitués en tant qu'inhibiteurs de kinases trk
KR20080081177A (ko) 야누스 키나아제 억제제인 술폰아미도아닐린 유도체
US20210139506A1 (en) Macrocyclic compounds as trk kinases inhibitors
US20240199623A1 (en) SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINES AS CFTR MODULATORS
KR20020041456A (ko) 9-치환 구아닌 유도체의 합성 및 사용 방법
KR20190025545A (ko) 특정 단백질 키나제 억제제
CN119264065A (zh) 一类细胞程序性坏死抑制剂及其制备方法和用途
CN102227429A (zh) 作为趋化因子受体调节剂的3-氨基环戊烷羧酰胺
RU2749038C2 (ru) Замещенные пирроло[2,3-d]пиридазин-4-оны и пиразоло[3,4-d]пиридазин-4-оны в качестве ингибиторов протеинкиназы
US6583138B1 (en) Heterocyclic-ring condensed benzothiazine compound
MXPA02004935A (es) Uso de derivados de hipoxantina 9-sustituida para estimular la regeneracion de tejido nervioso.
SK24393A3 (en) Carboxylic acid esters with 2-amino-7-(1,3-dihydroxy- -2-propoxymethyl)purine, their preparation and use
BR112018076622B1 (pt) Pirrolo[2,3-d]piridazin-4-onas e pirazolo[3,4- d]piridazin-4-onas substituídas, seu uso e composição farmacêutica que as compreendem
HK1126212B (en) Heterocyclic compounds and uses thereof in the treatment of sexual disorders

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees